Investigation of social, demographic and health variations in the usage of prescribed and over-the-counter medicines within a large cohort (South Yorkshire, UK) by Green, M.A. et al.
Investigation of social, demographic
and health variations in the usage of
prescribed and over-the-counter
medicines within a large cohort
(South Yorkshire, UK)
Mark A Green,1,2 Emma Little,2 Richard Cooper,2 Clare Relton,2 Mark Strong2
To cite: Green MA, Little E,
Cooper R, et al. Investigation
of social, demographic and
health variations in the usage
of prescribed and over-the-
counter medicines within a
large cohort
(South Yorkshire, UK). BMJ
Open 2016;6:e012038.
doi:10.1136/bmjopen-2016-
012038
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2016-012038).
Received 23 March 2016
Revised 25 August 2016
Accepted 31 August 2016
1Department of Geography
and Planning, University of
Liverpool, Liverpool, UK
2School of Health and
Related Research (ScHARR),
University of Sheffield,
Sheffield, UK
Correspondence to
Dr Mark A Green; mark.
green@liverpool.ac.uk
ABSTRACT
Objectives: Prescribed and over-the-counter
(non-prescribed) medicine usage has increased in
recent years; however, there has been less investigation
of the socioeconomic predictors of use. This has been
due to a lack of data, especially for over-the-counter
medicines. Our study aims to understand how
prescribed and over-the-counter medicine patterns vary
by demographic, social and health characteristics
within a large population cohort.
Design: Cross-sectional data analysis.
Setting: South Yorkshire, UK.
Participants: 27 806 individuals from wave 1 of the
Yorkshire Health Study (2010–2012).
Measures: Individuals self-reported each medicine
they were taking and whether each was prescribed or
not. The medicines were grouped into 14 categories
(eg, cardiovascular system, infection, contraception).
Negative binomial regression models were used to
analyse the count of medicine usage. We included
demographic (age, gender, ethnicity), social (education),
health-related (body mass index, smoking, alcohol
consumption, physical activity) factors and chronic
health conditions (eg, stroke, anxiety and heart disease)
in our analyses.
Results: 49% of men and 62% of women were taking
medicine with the majority of this prescribed (88% and
83%, respectively). Health conditions were found to be
positively associated with prescribed medicine usage, but
mixed in their associated with over-the-counter
medicines. Educational attainment was negatively
associated with prescribed and positively associated with
over-the-counter usage.
Conclusions: Our study addresses a dearth of evidence
to provide new insights into how behaviours in medicine
usage vary by demographic, social and health-related
factors. Differences in over-the-counter medicine usage
by educational attainment may help our understanding of
the determinants of health inequalities.
INTRODUCTION
There have been recognised increases in the
production, affordability and consumption of
medicines globally for many years,1 reﬂecting
a market of several hundreds of billions of
pounds. In England, for example, the total
volume of medicine taken across England has
grown with the total number of medicines pre-
scribed by general practitioners (GPs) tripling
in the 15 years up to 2010.2 This growth has
occurred during a period of rising life expect-
ancy, quality of life and better healthcare.
Over-the-counter (ie, non-prescribed and
not funded by the state) medicines represent
the other key supply route, and this also
represents a signiﬁcant market, with over 900
million packs being supplied in the UK in
2011.3 Indeed, the cost of medicines has been
the subject of increasing attention, where it
represents a key burden in healthcare systems
like the National Health System (NHS) in the
UK. Over-the-counter medicine use has been
argued to represent a potential saving by
reducing NHS spending by shifting the ﬁnan-
cial burden to individuals.4 However, the
approach also follows a wider NHS strategy to
enhance patient’s empowerment through
promoting self-medication contrary to other
European nations.5–7
Previous research into predictors of medi-
cine usage has focused on demographic
Strengths and limitations of this study
▪ We address a dearth of evidence on socio-
economic differences in terms of prescribed and
over-the-counter (non-prescribed) medication
usage (disaggregated by medicine type) using a
large secondary data set.
▪ Our data are self-reported and may be subject to
bias suggesting the need for objective data.
▪ Our analysis is only cross-sectional and extend-
ing this investigation longitudinally will be neces-
sary for assessing the importance of our results.
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factors, particularly age and gender. Prescribed medica-
tion usage has been shown to increase with age due to
the association between ill health and age,8–11 although
childhood and adolescence also represent important
focal points of research.12 13 In contrast, over-the-counter
medicine usage decreases with age.9 11 14 Differences in
terms of gender have also been explored extensively, with
women consistently found to use greater prescribed and
over-the-counter medicines.9–11 14–16 Women are more
health conscious than men, and have greater interactions
with healthcare systems, which might explain these differ-
ences.17 There has also been some investigation of
gender inequity in medication usage in low-income and
medium-income countries.17 18
There have been fewer studies that have explored the
inﬂuence of social determinants on medicine usage, par-
ticularly for over-the-counter medicines. This is despite a
more extensive literature on social inequalities in health,
health-related behaviours and health service usage.19
Inconsistent ﬁndings have been reported for patterns by
prescribed medicines usage, although this appears
dependent on the policy context.9–12 15 20 21 The associ-
ation for over-the-counter medicine usage appears clearer,
with greater usage among individuals of higher social
standing.9 11 14 21 However, there has been less investiga-
tion of the social determinants of over-the-counter medi-
cine due to a lack of available data. Understanding
differences in medicine usage is important in explaining
the existence of social inequalities in health.
There has been less investigation of population-level
associations within the UK, with most of the evidence
base conducted in the USA. This has been due to a lack
of available data, particularly for over-the-counter medi-
cines which represent important areas due to their
potential beneﬁts (saving GP time and NHS costs) and
problems (medicine interactions, side effects, misuse
and abuse22). Data sources often contain small sample
sizes, restricting the generalisability of ﬁndings. While
the Health Survey of England is the largest national
survey on health behaviours in England, it only contains
information on prescribed medicines.23 There has also
been a concentration of research exploring the uptake
of cardiovascular medicine,24 25 ignoring potential varia-
tions in other types of medicines.
Our study aims to understand how prescribed and
over-the-counter medicine patterns vary by demo-
graphic, social and health characteristics within a large
population cohort. We also disaggregate our analyses by
medicine type.
METHODS
Data
Data were taken from the ﬁrst wave (2010–2012) of the
Yorkshire Health Study (formerly the South Yorkshire
Cohort), a longitudinal observational survey.26 The ﬁrst
wave contained information on 27 806 individuals aged
16 and over that consisted of the South Yorkshire region
of England. Data were self-reported by individuals.
Records with missing medicine data were dropped,
leaving a total analytical sample of 18 272.
Individuals were asked to record any medicines they
were currently taking, including whether it was pre-
scribed or not. The data were then grouped into 14 cat-
egories (linked to the British National Formulary
(BNF)), loosely based on the area and organ system of
the body being targeted by the medicine (table 1). This
grouping system was selected to minimise overlap
between categories and follows previous research.8
Names of groups follow the BNF other than ‘Malignant
disease’ medication which we refer to as ‘chemother-
apy/immunosuppressant’ as it is a more useful descrip-
tor. We separated oral contraceptives and diabetes
medicine from other endocrine system agents. Oral con-
traceptives were considered separately to be able to
explore gender variations in endocrine system medicine
usage.16 Diabetes medicines were also separated due to
their high prevalence and relative importance in public
health decision-making.
Demographic factors included in our analysis were
age, gender and ethnicity since variations in medicine
use with respect to these factors have been previously
demonstrated.9 10 14 27 Age was measured as a continu-
ous variable (in years) and gender was measured as a
binary variable (male or female). Ethnicity was dichoto-
mised into White or Caucasian. We did not disaggregate
the Caucasian category further due to the lack of hetero-
geneity in the sample (ie, 5.9% of the sample were
Caucasian).
Education was the only social measure included.
Education has been used as a proxy for socioeconomic
status in previous research of medicine usage,10 11 20 21
since a higher level of education allows individuals to
access better employment opportunities and therefore
maximise their socioeconomic status.28 29 Education
also captures human capital which may inﬂuence
health-related behaviours through greater cognitive
ability to engage with health promotion resources.
Education was deﬁned using the following groups
(European Qualiﬁcations Framework (EQF) level pro-
vided); ‘no formal education’ (EQF level 1), ‘secondary
level of education’ (GCSE (General Certiﬁcate of
Secondary Education) level or equivalent; EQF level
2–3), ‘postsecondary level’ (A-level or equivalent; EQF
level 4) and ‘degree level or higher’ (EQF level 5+).
Heath-related behaviours were captured using body
weight, smoking, alcohol and physical activity beha-
viours. Body mass index (BMI) was used as a measure of
relative body weight since it has been shown to be posi-
tively associated with medicine usage.30 BMI is calculated
by dividing an individual’s weight (kg) by their height
squared (m2). Smoking status, alcohol consumption and
physical activity level were all included since they are
important predictors of health.31–37 Smoking status
refers to whether an individual currently smokes or not.
Alcohol consumption was measured as the number of
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units of alcohol consumed per week. Physical activity was
measured using two variables: level of walking and level
of physical exercise (eg, sport, gym). Each measure was
categorised as: ‘none’, ‘<1 hour’, ‘1–3 hours’ or
‘>3 hours’ per week.
We also examined the role of 12 chronic health condi-
tions. Individuals reported whether they had any of the
following long-standing conditions or disabilities;
fatigue, pain, insomnia, anxiety, depression, diabetes,
breathing problems (eg, chronic bronchitis), high blood
pressure, heart disease, osteoarthritis, stroke or cancer.
These were each individually included as explanatory
variables.
Each GP practice was included as a separate variable
in the analysis in order to account for differences in pre-
scribing patterns between surgeries (results not reported
due to the large number of surgeries).20
Statistical analysis
The prevalence of each medicine category was reported
and weighted using sample weights. Weighting was
necessary because the Yorkshire Health Study contains
some bias since it is over-representative of the elderly,
females and individuals from afﬂuent areas.26 Weighting
allowed us to correct for known bias (sample weights
were not used in the regression models). Analysis of
medicine usage was conducted using total medicines
split by prescription status. Medicine data were
considered to have a Poisson distribution; however, var-
iances were greater than mean values. To account for
the overdispersion, negative binomial regression models
were used to analyse medicine usage. Incident rate ratios
(IRR) and their 95% CIs were reported. All explanatory
variables were included in each multivariate model. GP
practice could not be included as a random effect in the
model since it resulted in the model becoming unstable
and unable to converge. The analysis was also repeated
for individual medicine categories to explore differences
between them. Only the most prevalent medicine types
(a sample size >10%; table 1) were selected to avoid
small sample size issues. All analyses were undertaken
using STATA/SE V.13.0.
RESULTS
Table 1 presents a summary of self-reported medicines
taken split by category and gender. A greater proportion
of women (62.2%) were found to be taking any category
of medicine in comparison to men (49.3%). However,
there was little difference in the mean number of any
medicine category taken. Cardiovascular system medi-
cines were the most common medicine taken, with
gastrointestinal system, CNS (central nervous system),
CNS pain and dietary supplements also commonly used.
There was little difference in the mean number of medi-
cines taken split by category or gender. The majority of
Table 1 Summary statistics on medicine usage, including the percentage of each category taken, the mean number taken
and the percentage of each prescribed (n=18 272)
Individuals taking
each medicine (%)
Mean number of
medicines taken*
Percentage of
medicines
prescribed (%)
Category Male Female Male Female Male Female
Cardiovascular system 24.3 21.3 2.7 2.4 97.7 97.0
Gastrointestinal system 12.1 14.6 1.2 1.3 94.9 92.4
CNS (central nervous system) 9.6 16.0 1.3 1.3 92.5 90.4
CNS pain 15.5 21.4 1.5 1.5 83.6 79.4
Respiratory system 8.1 8.4 1.8 1.9 99.1 99.3
Infection 2.9 2.7 1.6 1.1 94.7 96.7
Endocrine system 3.4 9.3 1.2 1.2 99.6 98.5
Contraception 0.0 7.5 0.0 1.0 NA 97.3
Chemotherapy/immunosuppressant 0.2 0.3 1.3 1.2 100 100
Musculoskeletal system 4.5 9.8 1.2 1.3 63.1 74.6
Eye 1.8 2.5 1.3 1.3 96.5 91.6
Allergy 4.2 4.6 1.2 1.1 78.3 79.4
Weight loss 0.4 0.5 1.0 1.0 71.4 83.6
Smoking cessation 0.1 0.1 1.1 1.0 100 91.9
Dietary supplements 9.3 17.3 1.5 1.5 27.7 25.5
Skin 3.1 4.1 1.5 1.4 92.2 85.1
Diabetes 4.1 2.6 1.5 1.4 99.3 99.8
Genito-urinary system 3.3 1.4 1.1 1.0 94.4 99.0
Gout 1.6 0.3 1.2 1.2 96.8 98.6
Other 2.6 3.5 1.1 1.1 72.5 47.1
Any category 49.3 62.2 3.7 3.6 88.1 82.5
Estimates weighted by age, gender, deprivation.
*Individuals not taking each medicine excluded.
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medicines taken were prescribed; however, the propor-
tion prescribed varied by category. Dietary supplements
were the only category with greater over-the-counter
medicines than prescribed medicines.
Table 2 presents the results from the regression
models exploring the association of our variables to the
number of prescribed and over-the-counter medicines
taken. Age was positively associated with greater pre-
scribed and over-the-counter medicine usage. Women
were more likely to take prescribed and over-the-counter
medicines. Although individuals from ethnic minority
groups were less likely to use prescribed medicine than
White individuals, there were no differences for
over-the-counter medicine. BMI was positively associated
with the number of prescribed medicines but unrelated
to over-the-counter medicine.
The chronic illness and health conditions variables
were consistently positively associated with greater pre-
scribed medicines taken, with only insomnia having no
signiﬁcant relationship. Diabetes, breathing problems,
high blood pressure and heart disease had stronger asso-
ciations than anxiety, stroke and fatigue. Negative
Table 2 Results from negative binomial regression models analysing the associated factors of medicine usage, split by
medicine type (n=18 272)
Total prescribed Total over-the-counter
Variable IRR (95% CI) IRR (95% CI)
Demographic
Age 1.025*** (1.024 to 1.027) 1.027*** (1.024 to 1.030)
Male 0.894*** (0.863 to 0.925) 0.600*** (0.553 to 0.651)
Caucasian 0.756*** (0.670 to 0.853) 0.805 (0.628 to 1.033)
Social
Education
None Reference Reference
Secondary 0.943** (0.904 to 0.985) 1.665*** (1.495 to 1.856)
Postsecondary 1.013 (0.951 to 1.080) 1.817*** (1.573 to 2.099)
Degree or higher 0.950* (0.906 to 0.997) 1.967*** (1.754 to 2.206)
Health-related
Body mass index 1.011*** (1.007 to 1.014) 1.001 (0.993 to 1.009)
Units of alcohol 0.995*** (0.993 to 0.996) 1.000 (0.996 to 1.004)
Smoker 1.065* (1.013 to 1.120) 0.786*** (0.695 to 0.888)
Walking (per week)
None Reference Reference
<1 hour 1.001 (0.933 to 1.074) 1.165 (0.957 to 1.418)
1–3 hours 0.976 (0.914 to 1.042) 1.355** (1.131 to 1.624)
3+ hours 0.938 (0.879 to 1.001) 1.500*** (1.253 to 1.795)
Physical exercise (per week)
None Reference Reference
<1 hour 0.947 (0.891 to 1.006) 1.156* (1.011 to 1.323)
1–3 hours 0.926** (0.884 to 0.971) 1.188** (1.074 to 1.313)
3+ hours 0.854*** (0.811 to 0.898) 1.231*** (1.106 to 1.370)
Chronic health
Fatigue 1.208*** (1.154 to 1.265) 1.052 (0.933 to 1.185)
Pain 1.528*** (1.467 to 1.593) 1.563*** (1.412 to 1.730)
Insomnia 1.007 (0.947 to 1.070) 1.116 (0.957 to 1.302)
Anxiety 1.155*** (1.093 to 1.221) 1.064 (0.925 to 1.224)
Depression 1.449*** (1.365 to 1.537) 1.141 (0.978 to 1.331)
Diabetes 1.807*** (1.708 to 1.912) 0.747** (0.628 to 0.888)
Breathing problems 1.949*** (1.861 to 2.041) 0.972 (0.858 to 1.101)
High blood pressure 1.907*** (1.835 to 1.983) 0.863** (0.776 to 0.959)
Heart disease 1.824*** (1.723 to 1.931) 0.771** (0.647 to 0.920)
Osteoarthritis 1.143*** (1.086 to 1.203) 1.280*** (1.127 to 1.453)
Stroke 1.259*** (1.146 to 1.384) 0.600** (0.438 to 0.824)
Cancer 1.276*** (1.174 to 1.387) 0.850 (0.676 to 1.069)
Constant 0.220*** (0.188 to 0.257) 0.054*** (0.037 to 0.078)
/ln α − 0.761 1.178
α 0.467 3.249
Pseudo r2 0.154 0.039
GP surgery was also adjusted for, including each surgery in the model as binary variables but not included in the table.
Significance levels: *<0.05, **<0.01, ***<0.001.
IRR, incident rate ratio.
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associations were found for the relationships between
over-the-counter medicine use and diabetes, high blood
pressure, stroke and heart disease. Pain and osteoarth-
ritis were signiﬁcantly and positively associated with
prescribed and over-the-counter medicine use.
Consumption of alcohol was negatively associated
with the number of prescribed medicines taken, but
smoking was associated with increased number of pre-
scribed medicines. For over-the-counter medicine, there
was no signiﬁcant association for alcohol, whereas the
relationship for smoking was reversed. Walking was not
associated with prescribed medicine, but positively asso-
ciated with over-the-counter medicine. Physical exercise
followed a similar pattern to walking for over-the-counter
medicines, but the relationship reversed for prescribed
medicine. Higher education levels were each negatively
associated with total prescribed medicine (in compari-
son to the ‘no qualiﬁcation’ category), although the
strength of each association was weak. This contrasted
with over-the-counter medicine, where education was
positively associated with the use of over-the-counter
medicines.
Tables 3 and 4 present the results of the negative bino-
mial regression for prescribed and over-the-counter
medicines, respectively. There were fewer signiﬁcant
associations; however, the results mostly followed the
ﬁndings from table 2, particularly for age, gender and
education. We observed some large effect sizes for some
chronic health conditions to prescribed medicines asso-
ciated with treating the condition (eg, cardiovascular
system medicine and individuals reporting high blood
pressure (IRR=4.205, 95% CIs 3.995 to 4.425)). These
associations were not always immediately obvious, with
depression strongly associated with CNS medicine
(IRR=4.210, 95% CIs 3.770 to 4.700) and fatigue asso-
ciated with dietary supplements (IRR=2.273, 95% CIs
1.877 to 2.752). Similar associations were not observed
for chronic health conditions and over-the-counter med-
icines, although chronic pain was signiﬁcantly positively
associated with each medicine type apart from cardiovas-
cular medicine. Some chronic health conditions were
also negatively associated with medicine usage (eg, dia-
betes and gastrointestinal system medicine; IRR=0.327,
95% CIs 0.142 to 0.752).
DISCUSSION
This study has demonstrated variations by demographic,
social and health factors in prescribed and
over-the-counter medicine usage within a large cohort.
Prescribed medicine usage was associated with the pres-
ence of chronic health conditions and poor
health-related behaviours. Taking over-the-counter medi-
cine was associated with higher levels of education, and
positive health behaviours. Gender was also important
for the purchasing of both medicine type, although the
effect size was larger for over-the-counter medicines.
The patterns were fairly consistent when analysing by
medicine type.
The main strength of the study is it addresses the
dearth of evidence of social and demographic patterns
in medicine usage at the population level, particularly
for over-the-counter medicines. There are several limita-
tions to our study. The analysis is cross-sectional and
therefore cannot demonstrate causality. Future waves of
the Yorkshire Health Study will allow the ﬁndings to be
tested longitudinally, helping to strengthen conclusions
and recommendations.26 Data collected in the Yorkshire
Health Study were self-reported and this may lead to
bias in estimates. For example, recall bias may lead to
under-reporting of medications, particularly for
over-the-counter medications which are taken sporadic-
ally or not always thought of as medicines (eg, vitamins).
Medicine dosage was not measured in the data limiting
our comparison of medicines. The categories used to
group together medicines may also hide variations in
patterns, particularly where medications may be used for
different purposes, despite operating at the same organ
system/area of the body. Finally, we only use one
measure of socioeconomic status (education) and
extending our analyses to additional measures such as
income or occupation will help to improve our under-
standing socioeconomic behaviours in medicine usage.
While individuals of high education took fewer medi-
cations compared with individuals with no qualiﬁcations
(table 2), the effect size was only small and medicine
usage was inﬂuenced more strongly by health status and
age. In contrast, a distinct social gradient in
over-the-counter medicine usage was observed. These
ﬁndings support similar results found in other coun-
tries.11 21 Individuals of high education are associated
with better employment prospects and higher incomes,
and hence they will be in a better position to absorb the
ﬁnancial burden associated with purchasing additional
medicines, particularly if it allows them to avoid long
waiting times to see their GP.9 11 21 Education also incor-
porates an individual’s ability to cognitively understand
the potential beneﬁts of over-the-counter medicines, as
well as effectively communicate health information to
clinicians.38 Alternative explanations for the role of edu-
cation may include: differences in compliance to treat-
ment, inequalities in access to pharmacies and variations
in self-treatment behaviours.10 11 Evaluating the contri-
bution of these potential pathways is important for
future research to be able to address social inequalities
in health behaviours.
The relationships for physical exercise, walking and
smoking may also be explained similarly to that of the
cognitive role of education. Individuals who exercise
regularly or do not smoke have been shown to have
greater health consciousness.39 40 Health consciousness
may be captured through these variables in our analysis
and it may be that these types of individuals also try to
maximise their health using over-the-counter medicines.
Given the association between high education and
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Table 3 Results of negative binomial regressions analysing prescribed medicine usage (n=18 272)
Cardiovascular system Gastrointestinal system CNS CNS pain Musculoskeletal system Dietary Supplements
Variable IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI)
Demographic
Age 1.054*** (1.052 to 1.056) 1.031*** (1.028 to 1.035) 1.013*** (1.009 to 1.016) 1.017*** (1.014 to 1.020) 1.056*** (1.049 to 1.062) 1.024*** (1.018 to 1.030)
Male 1.298*** (1.233 to 1.365) 0.897** (0.830 to 0.970) 0.694*** (0.632 to 0.763) 0.872*** (0.812 to 0.936) 0.440*** (0.381 to 0.509) 0.704*** (0.599 to 0.827)
Caucasian 0.723** (0.583 to 0.895) 0.523*** (0.369 to 0.742) 0.770 (0.570 to 1.041) 0.713* (0.546 to 0.931) 0.768 (0.445 to 1.325) 0.869 (0.507 to 1.489)
Social
Education
None Reference Reference Reference Reference
Secondary 0.955 (0.899 to 1.015) 0.974 (0.886 to 1.070) 0.959 (0.856 to 1.075) 1.099* (1.009 to 1.196) 0.915 (0.775 to 1.080) 0.954 (0.786 to 1.159)
Postsecondary 0.936 (0.846 to 1.036) 0.987 (0.851 to 1.145) 0.943 (0.798 to 1.115) 1.173* (1.032 to 1.333) 0.927 (0.711 to 1.209) 1.084 (0.814 to 1.443)
Degree or higher 0.856*** (0.800 to 0.917) 0.966 (0.867 to 1.077) 0.893 (0.782 to 1.020) 0.985 (0.888 to 1.093) 1.008 (0.837 to 1.213) 0.847 (0.677 to 1.061)
Health-related
Body mass index 1.032*** (1.027 to 1.037) 1.012** (1.005 to 1.019) 1.004 (0.996 to 1.012) 1.019*** (1.013 to 1.025) 0.962*** (0.949 to 0.975) 0.980** (0.965 to 0.994)
Units of alcohol 0.999 (0.997 to 1.002) 0.998 (0.994 to 1.002) 0.987*** (0.982 to 0.991) 0.991*** (0.988 to 0.995) 0.982*** (0.973 to 0.990) 0.985** (0.977 to 0.994)
Smoker 1.167*** (1.079 to 1.261) 0.934 (0.832 to 1.049) 1.200** (1.066 to 1.350) 1.303*** (1.187 to 1.430) 1.113 (0.907 to 1.365) 1.320* (1.067 to 1.633)
Walking (per week)
None Reference Reference Reference Reference Reference Reference
<1 hour 1.153** (1.045 to 1.273) 0.972 (0.849 to 1.114) 0.734*** (0.629 to 0.856) 0.897 (0.799 to 1.008) 1.049 (0.814 to 1.352) 0.821 (0.616 to 1.093)
1–3 hours 1.176** (1.072 to 1.289) 0.931 (0.820 to 1.058) 0.639*** (0.552 to 0.738) 0.777*** (0.696 to 0.868) 0.871 (0.686 to 1.106) 0.761* (0.583 to 0.994)
3+ hours 1.162** (1.059 to 1.274) 0.867* (0.762 to 0.987) 0.556*** (0.480 to 0.644) 0.756*** (0.676 to 0.845) 0.836 (0.658 to 1.062) 0.671** (0.513 to 0.877)
Physical exercise (per week)
None Reference Reference Reference Reference Reference Reference
<1 hour 0.955 (0.869 to 1.050) 0.884 (0.765 to 1.022) 0.834* (0.707 to 0.983) 0.972 (0.857 to 1.102) 0.935 (0.730 to 1.197) 1.000 (0.761 to 1.315)
1–3 hours 0.919 (0.854 to 0.989) 0.880* (0.787 to 0.985) 0.764*** (0.669 to 0.872) 0.859** (0.774 to 0.953) 1.032 (0.860 to 1.237) 0.892 (0.715 to 1.113)
3+ hours 0.927 (0.858 to 1.002) 0.787*** (0.692 to 0.896) 0.633*** (0.538 to 0.744) 0.720*** (0.634 to 0.817) 0.873 (0.703 to 1.083) 0.881 (0.686 to 1.130)
Chronic health
Fatigue 1.017 (0.953 to 1.085) 1.503*** (1.369 to 1.649) 1.213** (1.084 to 1.357) 1.099* (1.012 to 1.193) 1.646*** (1.393 to 1.943) 2.273*** (1.877 to 2.752)
Pain 1.047 (0.986 to 1.112) 1.833*** (1.678 to 2.003) 1.534*** (1.378 to 1.708) 5.088*** (4.695 to 5.514) 1.952*** (1.671 to 2.280) 1.232* (1.021 to 1.487)
Insomnia 0.954 (0.873 to 1.042) 1.017 (0.907 to 1.141) 0.926 (0.812 to 1.056) 1.060 (0.961 to 1.170) 1.069 (0.868 to 1.317) 0.949 (0.739 to 1.220)
Anxiety 1.109* (1.021 to 1.204) 1.178** (1.056 to 1.314) 2.138*** (1.912 to 2.390) 0.936 (0.850 to 1.032) 0.867 (0.704 to 1.066) 1.169 (0.925 to 1.478)
Depression 1.048 (0.957 to 1.147) 1.215** (1.081 to 1.366) 4.210*** (3.770 to 4.700) 1.312*** (1.186 to 1.451) 1.170 (0.933 to 1.467) 1.237 (0.964 to 1.587)
Diabetes 1.675*** (1.563 to 1.795) 0.895 (0.791 to 1.013) 0.965 (0.823 to 1.132) 0.878* (0.783 to 0.985) 0.955 (0.754 to 1.208) 1.613*** (1.258 to 2.068)
Breathing problems 0.983 (0.917 to 1.054) 1.237*** (1.123 to 1.362) 0.929 (0.821 to 1.052) 1.029 (0.941 to 1.124) 1.314** (1.103 to 1.566) 1.186 (0.962 to 1.461)
High blood pressure 4.205*** (3.995 to 4.425) 1.076 (0.989 to 1.172) 0.970 (0.868 to 1.085) 1.013 (0.937 to 1.096) 0.876 (0.750 to 1.022) 1.154 (0.962 to 1.384)
Heart disease 3.330*** (3.115 to 3.560) 1.377*** (1.236 to 1.535) 1.099 (0.940 to 1.284) 1.087 (0.977 to 1.210) 1.105 (0.893 to 1.367 1.232 (0.957 to 1.588)
Osteoarthritis 0.973 (0.909 to 1.042) 1.216*** (1.105 to 1.339) 0.978 (0.858 to 1.114) 1.720*** (1.587 to 1.866) 1.653*** (1.402 to 1.949) 1.099 (0.883 to 1.368)
Stroke 1.631*** (1.463 to 1.818) 1.097 (0.921 to 1.308) 1.238 (0.994 to 1.543) 1.002 (0.846 to 1.186) 1.012 (0.722 to 1.418) 0.912 (0.603 to 1.380)
Cancer 0.964 (0.862 to 1.078) 1.386*** (1.194 to 1.609) 0.959 (0.766 to 1.120) 1.127 (0.969 to 1.311) 1.290 (0.977 to 1.702) 1.325 (0.943 to 1.860)
Constant 0.005*** (0.003 to 0.006) 0.018*** (0.013 to 0.026) 0.085*** (0.058 to 0.125) 0.033*** (0.024 to 0.044) 0.010*** (0.005 to 0.018) 0.028*** (0.014 to 0.055)
ln α −0.906 −1.327 −0.628 −1.175 0.909 1.344
α 0.404 0.265 0.534 0.309 2.481 3.836
Pseudo r2 0.284 0.142 0.176 0.208 0.144 0.082
GP surgery was also adjusted for, including each surgery in the model as binary variables but not included in the table.
Significance levels: *<0.05, **<0.01, ***<0.001.
CNS, central nervous system; IRR, incident rate ratio.
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Table 4 Results of negative binomial regressions analysing over-the-counter medicine usage (n=18 272)
Cardiovascular system Gastrointestinal system CNS CNS pain Musculoskeletal system Dietary Supplements
Variable IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI)
Demographic
Age 1.052*** (1.042 to 1.063) 1.033*** (1.023 to 1.044) 0.995 (0.985 to 1.004) 1.009** (1.003 to 1.015) 1.057*** (1.050 to 1.064) 1.031*** (1.027 to 1.034)
Male 0.963 (0.765 to 1.212) 0.505*** (0.377 to 0.675) 0.493*** (0.366 to 0.664) 0.597*** (0.509 to 0.701) 0.624*** (0.530 to 0.736) 0.573*** (0.519 to 0.633)
Caucasian 0.769 (0.304 to 1.947) 1.305 (0.591 to 2.877) 1.147 (0.569 to 2.314) 0.720 (0.433 to 1.196) 0.953 (0.501 to 1.814) 0.746 (0.542 to 1.027)
Social
Education
None Reference Reference Reference Reference Reference Reference
Secondary 1.465** (1.101 to 1.949) 3.162*** (2.155 to 4.639) 1.665* (1.126 to 2.463) 1.883*** (1.523 to 2.328) 1.700*** (1.380 to 2.094) 1.659*** (1.454 to 1.892)
Postsecondary 1.342 (0.859 to 2.095) 3.457*** (2.113 to 5.656) 2.346*** (1.476 to 3.730) 2.032*** (1.542 to 2.676) 1.486* (1.082 to 2.041) 1.806*** (1.514 to 2.155)
Degree or higher 1.539** (1.130 to 2.096) 2.862*** (1.878 to 4.361) 1.916** (1.253 to 2.928) 1.943*** (1.541 to 2.450) 2.051*** (1.651 to 2.549) 2.045*** (1.781 to 2.348)
Health-related
Body mass index 1.036** (1.013 to 1.059) 0.989 (0.963 to 1.015) 1.034** (1.011 to 1.058) 1.021** (1.006 to 1.035) 1.004 (0.987 to 1.021) 0.986** (0.976 to 0.996)
Units of alcohol 1.003 (0.992 to 1.013) 1.004 (0.991 to 1.018) 1.000 (0.987 to 1.014) 1.000 (0.992 to 1.008) 1.007 (0.999 to 1.014) 0.998 (0.993 to 1.003)
Smoker 1.412* (1.016 to 1.961) 0.603* (0.379 to 0.962) 1.375 (0.987 to 1.915) 0.897 (0.717 to 1.122) 0.669* (0.490 to 0.913) 0.690*** (0.590 to 0.808)
Walking (per week)
None Reference Reference Reference Reference Reference Reference
<1 hour 2.193* (1.141 to 4.214) 0.721 (0.379 to 1.372) 0.546 (0.267 to 1.115) 1.268 (0.885 to 1.816) 0.997 (0.647 to 1.536) 1.174 (0.916 to 1.505)
1–3 hours 2.291** (1.228 to 4.275) 1.250 (0.718 to 2.177) 1.305 (0.728 to 2.337) 1.375 (0.985 to 1.920) 1.218 (0.823 to 1.801) 1.403** (1.116 to 1.764)
3+ hours 3.106*** (1.676 to 5.758) 1.004 (0.574 to 1.756) 1.631 (0.918 to 2.896) 1.422* (1.021 to 1.982) 1.622* (1.104 to 2.384) 1.519*** (1.211 to 1.907)
Physical exercise (per week)
None Reference Reference Reference Reference Reference Reference
<1 hour 1.308 (0.899 to 1.903) 1.045 (0.658 to 1.660) 0.962 (0.620 to 1.490) 0.963 (0.742 to 1.251) 1.259 (0.950 to 1.669) 1.158 (0.983 to 1.363)
1–3 hours 0.906 (0.660 to 1.244) 1.231 (0.894 to 1.694) 0.910 (0.652 to 1.271) 0.971 (0.800 to 1.180) 1.511*** (1.248 to 1.829) 1.227** (1.089 to 1.383)
3+ hours 1.029 (0.746 to 1.421) 1.190 (0.831 to 1.702) 0.760 (0.509 to 1.136) 0.939 (0.757 to 1.163) 1.645*** (1.351 to 2.003) 1.334*** (1.175 to 1.514)
Chronic health
Fatigue 1.027 (0.741 to 1.425) 1.033 (0.720 to 1.483) 0.860 (0.592 to 1.249) 1.076 (0.872 to 1.327) 0.806 (0.627 to 1.035) 1.086 (0.940 to 1.254)
Pain 1.192 (0.896 to 1.585) 1.938*** (1.424 to 2.639) 2.765*** (2.027 to 3.772) 3.457*** (2.908 to 4.111) 1.449*** (1.192 to 1.763) 1.140* (1.005 to 1.293)
Insomnia 1.084 (0.715 to 1.645) 0.989 (0.642 to 1.522) 1.554* (1.031 to 2.342) 1.084 (0.834 to 1.408) 1.135 (0.843 to 1.528) 1.091 (0.907 to 1.311)
Anxiety 1.114 (0.756 to 1.640) 1.505* (1.031 to 2.197) 1.228 (0.830 to 1.816) 1.009 (0.792 to 1.286) 0.701* (0.509 to 0.963) 1.079 (0.911 to 1.277)
Depression 0.940 (0.601 to 1.471) 1.364 (0.888 to 2.094) 1.360 (0.902 to 2.052) 1.131 (0.871 to 1.469) 0.880 (0.612 to 1.266) 1.201 (0.996 to 1.447)
Diabetes 0.840 (0.559 to 1.263) 0.327** (0.142 to 0.752) 0.456* (0.210 to 0.994) 0.857 (0.616 to 1.194) 0.597* (0.403 to 0.883) 0.770* (0.623 to 0.952)
Breathing problems 0.615* (0.412 to 0.917) 1.121 (0.764 to 1.646) 0.772 (0.496 to 1.200) 0.991 (0.786 to 1.249) 0.925 (0.714 to 1.197) 1.042 (0.897 to 1.210)
High blood pressure 1.189 (0.922 to 1.533) 0.952 (0.684 to 1.326) 0.808 (0.548 to 1.192) 0.653*** (0.527 to 0.810) 0.682*** (0.557 to 0.834) 0.976 (0.861 to 1.106)
Heart disease 1.103 (0.751 to 1.618) 0.855 (0.491 to 1.491) 0.850 (0.423 to 1.709) 0.489*** (0.329 to 0.725) 0.599** (0.416 to 0.863) 0.861 (0.698 to 1.061)
Osteoarthritis 1.015 (0.729 to 1.412) 1.646** (1.165 to 2.324) 1.359 (0.909 to 2.031) 1.359** (1.088 to 1.700) 1.720*** (1.403 to 2.107) 1.268** (1.089 to 1.477)
Stroke 1.225 (0.664 to 2.262) 0.545 (0.170 to 1.749) 0.490 (0.119 to 2.025) 0.842 (0.471 to 1.504) 0.337* (0.138 to 0.822) 0.560** (0.374 to 0.840)
Cancer 0.624 (0.322 to 1.209) 0.421 (0.155 to 1.148) 1.514 (0.766 to 2.990) 0.903 (0.584 to 1.396) 1.134 (0.777 to 1.655) 0.840 (0.637 to 1.107)
Constant 0.000*** (0.000 to 0.000) 0.001*** (0.000 to 0.004) 0.004*** (0.001 to 0.012) 0.011*** (0.006 to 0.023) 0.001*** (0.000 to 0.002) 0.033*** (0.021 to 0.052)
ln α 0.954 −0.118 −35.436 1.382 −1.068 1.164
α 2.595 0.889 0.000 3.981 0.344 3.202
Pseudo r2 0.072 0.087 0.0829 0.062 0.110 0.047
GP surgery was also adjusted for, including each surgery in the model as binary variables but not included in the table.
Significance levels: *<0.05, **<0.01, ***<0.001.
CNS, central nervous system; IRR, incident rate ratio.
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positive health-related behaviours throughout the litera-
ture,19 the role played by cognition appears important.
This is contrary to the relationships with prescribed
medicine where physical exercise is protective to
health35–37 and smoking damaging,31 33 34 independ-
ently inﬂuencing the need for prescribed medicine.
However, the results for alcohol consumption only fol-
lowed this pattern for prescribed medicine.
Individuals who were Caucasian were found to be less
likely to take prescribed medicines (but not
over-the-counter medicines). Our results support evi-
dence from the USA which has found similar associa-
tions of lower medicine usage among Caucasian
individuals.14 41 However, there is little understanding of
why this association exists and therefore, further
research should explore possible explanations, including
social factors, access to healthcare or cultural factors.
Addressing inequalities in healthcare usage by ethnicity
will be important, given that most medicines are only
available through prescriptions in the UK.
In summary, we ﬁnd differences in prescribed and
over-the-counter medicine usage by demographic, social
and health characteristics. Education was an important
factor in explaining variations in over-the-counter usage.
With the NHS moving towards greater self-medication
(to empower patients and reduce costs), such an
approach may have important implications for social
inequalities in health and health-related behaviours.
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@StrongScHARR
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